Similarly, the presence of Th17 cells and interleukin (IL)-17 was probably associated with the progression of different malignancies such as CRC, lung cancer, breast cancer, ovarian cancer, and gastric cancer 43-46. This evidence concerns the gene IL17A and lung carcinoma.